HIV-Specific T-cells in cerebrospinal fluid (CSF)
脑脊液 (CSF) 中的 HIV 特异性 T 细胞
基本信息
- 批准号:6889169
- 负责人:
- 金额:$ 18.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-03 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS /HIV neuropathy AIDS therapy HIV infections cell migration central nervous system cerebrospinal fluid chemokine clinical research cytokine receptors cytotoxic T lymphocyte cytotoxicity enzyme linked immunosorbent assay flow cytometry human subject interferon gamma leukocyte activation /transformation longitudinal human study neuroimmunomodulation patient oriented research plasma tumor necrosis factor alpha virus replication
项目摘要
DESCRIPTION (provided by applicant): This proposal responds to PA-01-072, "HIV-1 Infection of the Central Nervous System (CNS)." This study has two major goals. The first goal is to elucidate the mechanisms driving the trafficking of immune effector cells, particularly cytotoxic T-cells (CTL), to the CNS, and the effector functions of these cells that may either palliate or exacerbate neuropathogenesis. The second goal is to determine the relationship between trafficking of antiviral T-cells to cerebrospinal fluid (CSF) and viral load, antiretroviral therapy, and development of neurological disease. In preliminary studies, we determined that multiparameter flow cytometry may be used to detect antigen-specific CD8+ T-cells obtained "ex vivo" from 5-10 ml of CSF. In Specific Aim 1, we will study the frequency and trafficking patterns of HIV-specific CTL in CSF, and determine the relationship of CTL frequency in CSF to systemic and intrathecal immune activation, chemokine expression, HIV viral load and development of CNS disease. In Specific Aim 2, we will assess the effector functions of CSF CTL, including secretion of proinflammatory cytokines (IFN-gamma,, TNF-alpha), cytolytic effector molecules (i.e., perforin, granzymes), and MHC class I restricted lysis of target cells. We will also assess the clonality of HIV-specific CTL in CSF and peripheral blood, and determine the extent of"overlap" between these two populations. Two studies will be performed: first, a cross-sectional study of 25 HIV-infected patients with detectable HIV-specific CTL in perpheral blood; second, a longitudinal study of 40 HIV-infected patients including 10 who are stopping or interrupting highly-active antiretroviral therapy (HAART), 10 who are beginning HAART, 10 clinically stable individuals not on HAART and 10 with symptoms of neurological disease. We hypothesize that systemic lymphocyte activation (including upregulation of LFA-1 and VLA-4) leads to increased extravasation of activated lymphocytes into CSF, and that viral replication within the CNS, followed by a local inflammatory response and secretion of chemokines (i.e., IP-10, MIP-1alpha and MIP-1beta,RANTES) contributes to recruitment of cells expressing receptors for these chemokines in a non antigen-specific manner. We also hypothesize that there may be a correlation between intrathecal HIV viral load and T-cell recruitment to CSF, and that the presence of CTL in CSF may be predictive of neurological disease.
描述(由申请人提供):本提案响应PA-01-072,“HIV-1中枢神经系统(CNS)感染”。这项研究有两个主要目标。第一个目标是阐明驱动免疫效应细胞,特别是细胞毒性t细胞(CTL)向中枢神经系统运输的机制,以及这些细胞的效应功能可能减轻或加剧神经发病机制。第二个目标是确定抗病毒t细胞向脑脊液(CSF)转运与病毒载量、抗逆转录病毒治疗和神经系统疾病发展之间的关系。在初步研究中,我们确定多参数流式细胞术可用于检测从5-10 ml CSF中“体外”获得的抗原特异性CD8+ t细胞。在Specific Aim 1中,我们将研究CSF中HIV特异性CTL的频率和运输模式,并确定CSF中CTL频率与全身和鞘内免疫激活、趋化因子表达、HIV病毒载量和中枢神经系统疾病发展的关系。在Specific Aim 2中,我们将评估CSF CTL的效应功能,包括促炎细胞因子(ifn - γ、tnf - α)、细胞溶解效应分子(即穿孔素、颗粒酶)和MHC I类限制靶细胞裂解的分泌。我们还将评估CSF和外周血中hiv特异性CTL的克隆性,并确定这两个人群之间的“重叠”程度。将进行两项研究:首先,对25名外周血中可检测到hiv特异性CTL的hiv感染患者进行横断面研究;第二,对40名艾滋病毒感染者进行纵向研究,包括10名正在停止或中断高活性抗逆转录病毒治疗(HAART)的患者,10名正在开始HAART治疗的患者,10名未接受HAART治疗的临床稳定患者和10名有神经系统疾病症状的患者。我们假设,全身性淋巴细胞活化(包括LFA-1和VLA-4的上调)导致活化淋巴细胞外渗增加进入脑脊液,而病毒在中枢神经系统内的复制,随后是局部炎症反应和趋化因子(即IP-10、mip -1 α和mip -1 β、RANTES)的分泌,有助于以非抗原特异性的方式募集表达这些趋化因子受体的细胞。我们还假设鞘内HIV病毒载量与t细胞募集到CSF之间可能存在相关性,并且CSF中CTL的存在可能预测神经系统疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara L. Shacklett其他文献
Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis
- DOI:
10.1007/s10461-019-02651-0 - 发表时间:
2019-09-04 - 期刊:
- 影响因子:2.400
- 作者:
James Stannah;Romain Silhol;Jocelyn Elmes;Branwen Owen;Barbara L. Shacklett;Peter Anton;Ian McGowan;Ariane van der Straten;Dobromir Dimitrov;Rebecca F. Baggaley;Marie-Claude Boily - 通讯作者:
Marie-Claude Boily
Barbara L. Shacklett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara L. Shacklett', 18)}}的其他基金
UC Davis Shared Astrios Cell Sorter
加州大学戴维斯分校共享 Astrios 细胞分选机
- 批准号:
8826347 - 财政年份:2015
- 资助金额:
$ 18.57万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
8077555 - 财政年份:2010
- 资助金额:
$ 18.57万 - 项目类别:
CNS Immune/Inflammatory Biomarkers in HIV Controllers
HIV 控制者的中枢神经系统免疫/炎症生物标志物
- 批准号:
7939616 - 财政年份:2009
- 资助金额:
$ 18.57万 - 项目类别:
Immunopathogenesis of HIV in the Female Reproductive Tract
女性生殖道中艾滋病毒的免疫发病机制
- 批准号:
7684933 - 财政年份:2009
- 资助金额:
$ 18.57万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
8668880 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
Frequency and Function of HIV-specific T-cells in GALT
GALT 中 HIV 特异性 T 细胞的频率和功能
- 批准号:
6589886 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
7755799 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
Cell-mediated immune responses to HIV-1 in GALT
GALT 中细胞介导的针对 HIV-1 的免疫反应
- 批准号:
6775648 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
Cell-mediated immune responses to HIV-1 in GALT
GALT 中细胞介导的针对 HIV-1 的免疫反应
- 批准号:
6982786 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
9067880 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
相似海外基金
Basic and applied study on AIDS-therapy using hybrid liposomes
混合脂质体治疗艾滋病的基础与应用研究
- 批准号:
24656509 - 财政年份:2012
- 资助金额:
$ 18.57万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
艾滋病治疗多重耐药性的 SIV 模型
- 批准号:
6940442 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
艾滋病治疗抵抗力的 RT-SHIV 模型
- 批准号:
6940441 - 财政年份:2003
- 资助金额:
$ 18.57万 - 项目类别:
Mitochondrial Toxicity of Antiviral Nucleosides in AIDS Therapy
艾滋病治疗中抗病毒核苷的线粒体毒性
- 批准号:
7421121 - 财政年份:2002
- 资助金额:
$ 18.57万 - 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
- 批准号:
7479315 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
- 批准号:
6312501 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
- 批准号:
6499098 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
- 批准号:
7666728 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
- 批准号:
6708893 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
- 批准号:
6849724 - 财政年份:2001
- 资助金额:
$ 18.57万 - 项目类别: